An Emerging Regulatory Role for the Tumor Microenvironment in the DNA Damage Response to Double-Strand Breaks
- PMID: 31676722
- PMCID: PMC7002210
- DOI: 10.1158/1541-7786.MCR-19-0665
An Emerging Regulatory Role for the Tumor Microenvironment in the DNA Damage Response to Double-Strand Breaks
Abstract
Radiation, alkylating agents, and platinum-based chemotherapy treatments eliminate cancer cells through the induction of excessive DNA damage. The resultant DNA damage challenges the cancer cell's DNA repair capacity. Among the different types of DNA damage induced in cells, double-strand breaks (DSB) are the most lethal if left unrepaired. Unrepaired DSBs in tumor cells exacerbate existing gene deletions, chromosome losses and rearrangements, and aberrant features that characteristically enable tumor progression, metastasis, and drug resistance. Tumor microenvironmental factors like hypoxia, inflammation, cellular metabolism, and the immune system profoundly influence DSB repair mechanisms. Here, we put into context the role of the microenvironment in governing DSB repair mechanisms.
©2019 American Association for Cancer Research.
Conflict of interest statement
The authors declare no potential conflicts of interest.
Figures



Similar articles
-
Ionizing radiation and genetic risks. XVII. Formation mechanisms underlying naturally occurring DNA deletions in the human genome and their potential relevance for bridging the gap between induced DNA double-strand breaks and deletions in irradiated germ cells.Mutat Res. 2013 Oct-Dec;753(2):114-130. doi: 10.1016/j.mrrev.2013.07.003. Epub 2013 Aug 12. Mutat Res. 2013. PMID: 23948232 Review.
-
Tumor hypoxia as a modifier of DNA strand break and cross-link repair.Curr Mol Med. 2009 May;9(4):401-10. doi: 10.2174/156652409788167050. Curr Mol Med. 2009. PMID: 19519397 Review.
-
Analysis of the mobility of DNA double-strand break-containing chromosome domains in living mammalian cells.Methods Mol Biol. 2008;463:309-20. doi: 10.1007/978-1-59745-406-3_19. Methods Mol Biol. 2008. PMID: 18951175
-
Detection of DNA double-strand breaks by pulsed-field gel electrophoresis.Genes Cells. 2017 Jan;22(1):84-93. doi: 10.1111/gtc.12457. Epub 2016 Dec 15. Genes Cells. 2017. PMID: 27976495
-
Detection of DNA Double-Strand Breaks Using Pulsed-Field Gel Electrophoresis.Methods Mol Biol. 2019;2031:301-311. doi: 10.1007/978-1-4939-9646-9_16. Methods Mol Biol. 2019. PMID: 31473967
Cited by
-
DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.J Biol Chem. 2023 Jan;299(1):102787. doi: 10.1016/j.jbc.2022.102787. Epub 2022 Dec 9. J Biol Chem. 2023. PMID: 36509141 Free PMC article.
-
The Influence of Cell Cycle Regulation on Chemotherapy.Int J Mol Sci. 2021 Jun 28;22(13):6923. doi: 10.3390/ijms22136923. Int J Mol Sci. 2021. PMID: 34203270 Free PMC article. Review.
-
Impact of Chemotherapy on Vaccine Immunogenicity and Revaccination Response of Acute Lymphoblastic Leukemia-A Systematic Review and Meta-Analysis.Vaccines (Basel). 2025 Jun 1;13(6):605. doi: 10.3390/vaccines13060605. Vaccines (Basel). 2025. PMID: 40573936 Free PMC article. Review.
-
Integrin α6β4 signals through DNA damage response pathway to sensitize breast cancer cells to cisplatin.Front Oncol. 2022 Nov 10;12:1043538. doi: 10.3389/fonc.2022.1043538. eCollection 2022. Front Oncol. 2022. PMID: 36439467 Free PMC article.
-
Overcoming Chemotherapy Resistance in Germ Cell Tumors.Biomedicines. 2022 Apr 22;10(5):972. doi: 10.3390/biomedicines10050972. Biomedicines. 2022. PMID: 35625709 Free PMC article. Review.
References
-
- Lee JK, Choi YL, Kwon M, Park PJ. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies. Annual review of pathology. 2016;11:283–312. - PubMed
-
- Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Experimental dermatology. 2007;16:532–44. - PubMed
-
- Choi M, Kipps T, Kurzrock R. ATM Mutations in Cancer: Therapeutic Implications. Molecular cancer therapeutics. 2016;15:1781–91. - PubMed
-
- Walsh CS. Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy. Gynecologic oncology. 2015;137:343–50. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical